Ei Hospital Reproductive Center, Japan: A Global Pioneer in Reproductive Medicine Innovation

At the World Fertility Industry Alliance (WFA) Brand Summit held on April 26, 2024, Ms. Ren Jianli, representative of Ei Hospital Reproductive Center, Japan, presented the center’s outstanding achievements and cutting-edge technologies in reproductive medicine to attendees. Renowned for its exceptional clinical expertise, highly skilled medical team, and state-of-the-art equipment, Ei Hospital Reproductive Center has earned global patient trust—and through deep research and continuous innovation, it offers unprecedented hope to individuals and couples facing infertility.
At the World Fertility Industry Alliance (WFA) Brand Summit held on April 26, 2024, Ms. Ren Jianli, representative of Ei Hospital Reproductive Center, Japan, presented the center’s outstanding achievements and cutting-edge technologies in reproductive medicine to attendees. Renowned for its exceptional clinical expertise, highly skilled medical team, and state-of-the-art equipment, Ei Hospital Reproductive Center has earned global patient trust—and through deep research and continuous innovation, it offers unprecedented hope to individuals and couples facing infertility.
The founder of Ei Hospital Reproductive Center is the distinguished medical doctor, Dr. Masahide Shiotani. As President of the Japanese Society of In Vitro Fertilization (JSIVF) and Chairman of the Board of Ei Hospital Reproductive Center, USA, Dr. Shiotani commands exceptional prestige and profound expertise in reproductive medicine. He has long dedicated himself to clinical treatment and research in infertility—achieving remarkable results particularly in treating advanced maternal age infertility. He successfully developed the SEET (Sperm-Egg-Embryo Transfer) method and the two-stage embryo transfer technique, and pioneered the “Precision-Positioning Embryo Transfer” method—a technology enabling more accurate placement of embryos at the optimal uterine implantation site, significantly improving pregnancy rates.
Beyond Dr. Shiotani’s exceptional contributions, Ei Hospital Reproductive Center boasts a team of 46 outstanding embryologists. Most hold academic backgrounds in cell biology and have undergone rigorous training and extensive hands-on practice, mastering advanced embryo culture techniques. During embryo culture, they strictly adhere to meticulous procedural guidelines to ensure every step meets the highest international standards. Additionally, the center has introduced advanced equipment—including embryo warming workstations, Piezo-acoustic vibration micro-manipulation systems, and Time-lapse embryo monitoring systems—creating superior conditions for embryo culture and transfer.
Ei Hospital Reproductive Center enjoys an outstanding reputation across the industry. According to the special feature “The Strength of Hospitals,” published by Yomiuri Shimbun, the center ranks among the top performers nationwide in infertility treatment. Annually, it treats over 100,000 patients and completes approximately 10,000 treatment cycles. Behind these figures lies the center’s unwavering commitment to personalized, compassionate, and meticulous care for every patient.
In addition to clinical services, Ei Hospital Reproductive Center actively conducts scientific research to advance reproductive medicine. It maintains close collaborations with research institutions and experts worldwide to jointly explore novel therapies and technologies. A major breakthrough is the Shawkea DE-T1 formulation—a proprietary preparation derived from natural traditional Chinese medicinal herbs. Clinically validated, this formulation significantly improves premature ovarian insufficiency (POI), delays menopause onset, and enhances oocyte quality and pregnancy rates. This research achievement not only brings new hope to patients struggling with infertility but also injects fresh momentum into the broader field of reproductive medicine.
With its exceptional clinical expertise, highly specialized medical team, and advanced medical infrastructure, Ei Hospital Reproductive Center has achieved remarkable success in reproductive medicine. It delivers comprehensive, precise, and effective treatment services to patients while simultaneously driving progress in the field through rigorous scientific inquiry. As reproductive medicine continues to evolve, Ei Hospital Reproductive Center is poised to bring even greater benefits to individuals and couples confronting infertility.
[图片:https://cdn.yun.sooce.cn/6/59417/png/1747709268589227400debccf91678064ca3b83d33370.png?version=0][Ei Hospital Reproductive Center, Japan – Exterior view of the facility]
This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.
Key Facts
- ▸The Japan Yinge Hospital Reproductive Center showcased its outstanding achievements in reproductive medicine at the 2024 WFA Brand Summit.
- ▸The center was founded by Dr. Masahide Shioya, who has made significant achievements in infertility treatment.
- ▸The center has 46 professional embryologists and advanced equipment to ensure high-quality embryo culture.
- ▸It treats over 100,000 patients annually and completes about 10,000 treatment cycles.
- ▸They developed the Shawkea DE-T1 preparation, which can improve ovarian insufficiency and increase pregnancy rates.
